Oliver M. Fisher, MD, PhD, FMH (Surgery), FRACS
@omaxfisher
Surgeon-Scientist, GI Surgical Oncology & Upper GI Surgery, Oncogenomics Dreamer, Bioinformatics & Stats Lover, Father of 3 & Husband of 1 Awesome Burns Surgeon
ID: 1546951136
26-06-2013 00:19:15
2,2K Tweet
835 Takipçi
483 Takip Edilen
Pls read this excellent commentary by Beate Rau. She nails the topic&issues on the head. #HIPEC should be delivered at a minimum in a registry but even better trial setting as the effects are unclear. Markus W. Löffler, MD & I have written about this in the past doi.org/10.1007/s12254…
A comparison of outcomes including bile duct injury of subtotal cholecystectomy versus open total cholecystectomy as bailout procedures for severe cholecystitis: A multicenter real-world study SURGERY Journal surgjournal.com/article/S0039-…
1:2 - Transmet trial presented at ASCO #ASCO24. Is this the new standard for unresectable colorectal liver metastases? What do people think? Jordan Kharofa Shimul A. Shah Davendra Sohal IHPBA Julio Mayol Tom Varghese Jr. MD, MS, MBA, FACS, MAMSE 🇺🇸 Flavio G Rocha, MD, FACS, FSSO Skye C. Mayo, MD, MPH Jash Datta, MD
🚨🚨🚨 #ESOPEC🚨🚨🚨 🔥Practice shifting trial🔥 Patients with resectable, locally advanced, esophagus/GEJ adenocarcinoma Randomized Peri-op FLOT (FLOT4) vs Pre-operative chemoradiation (CROSS) Congrats to the study investigators! Let’s dive in! #ASCO24 Mayo Clinic Radiation Oncology 1/
I've never believed in neoadjuvant CRT for patients w/ esophageal adenocarcinoma, thinking heavily influenced by nasser altorki & Lorenzo Ferri MD PhD. Certainly ESOPEC supports that stance, although differing systemic regimens complicates. pubmed.ncbi.nlm.nih.gov/30278165/ pubmed.ncbi.nlm.nih.gov/26916717/
MOSAIC was published today in JACC Journals Bariatric surgery in patients with obstructive #sleep apnea (#OSA) and #obesity: ✨42% ⬇️ MACE ✨37% ⬇️ Death ✨70% ⬇️ Heart Failure ✨24% weight loss at 10-years dx.doi.org/10.1016/j.jacc… #cardiactwitter
Laparoscopic Spleen-Preserving Hilar Lymphadenectomy for Advanced Proximal Gastric Cancer Without Greater Curvature Invasion: Five-Year Outcomes From the Fuges-02 Randomized Clinical Trial JAMA Surgery jamanetwork.com/journals/jamas…
Siewert Classification for GE Junction tumors. 👇🏼👇🏼 SAGES is in Long Beach in 2025! SSAT Julio Mayol
Nice study on futility model for up-front resection in “resectable” PDAC. Occurs ~20% of the time and ~30% of patients never see systemic therapy. The sequence matters! Victoria Wu Stefano Crippa Giuseppe Malleo Roberto Salvia Syed A. Ahmad Flavio G Rocha, MD, FACS, FSSO jamanetwork.com/journals/jamas…
Robert Sutcliffe IHPBA GBIHPBA E-AHPBA Pancreatic Cancer UK EPC-Europ Pancr Club Pancreas Verona panc Data suggests “high risk” glands should leak less than 50% of the time (if you are technically competent), so committing a high-risk patient to 100% chance of EPI and DM seems a bit extreme as a baseline approach. If you can’t sew and/or gland falls apart, I guess bets are off…
Early 50s. No comorbs. Biopsy proven poorly diff OAC (no signet). Has this biopsy proven node below clavicles. “Locoregional” or M1? Curative intent FLOT followed by surgery or palliative? How long FLOT if 4 surgery? Lorenzo Ferri MD PhD Ewen A Griffiths Tim Underwood Sheraz Markar
The Residency Interview youtu.be/k2BEA8mNXPg?si… via Dr. Glaucomflecken addressing one of things I always say: not everyone has to be an academic! We also just need good doctors who know how to take care of patients!